Opportunity

Brokerage Service

  • Catapult Cell & Gene Therapy

F02: Contract notice

Notice reference: 2021/S 000-030672

Published 9 December 2021, 12:55pm



Section one: Contracting authority

one.1) Name and addresses

Catapult Cell & Gene Therapy

CM72YW

Braintree

CM72YW

Contact

Tony Morris

Email

Tony.Morris@ct.Catapult.org.uk

Country

United Kingdom

NUTS code

UKH25 - Central Bedfordshire

National registration number

07964711

Internet address(es)

Main address

http://ct.catapult.org.uk

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://catapultmic.wax-live.com/S2C/SignIn.aspx

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://catapultmic.wax-live.com/S2C/SignIn.aspx

one.4) Type of the contracting authority

Regional or local Agency/Office

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Brokerage Service

Reference number

KOJEU-022

two.1.2) Main CPV code

  • 66523000 - Pension fund consultancy services

two.1.3) Type of contract

Services

two.1.4) Short description

The provision of a Pension & Benefits Brokerage service. This Request for Proposal (?RfP?) has been issued on behalf of the Catapult consortium as part of a competitive procurement exercise in accordance with the "Restricted" procedure for tendering under the Public Contracts Regulations 2015 (as amended from time to time).

two.1.5) Estimated total value

Value excluding VAT: £20,000,000

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKH25 - Central Bedfordshire

two.2.4) Description of the procurement

The provision of a Pension & Benefits Brokerage service. This Request for Proposal (?RfP?) has been issued on behalf of the Catapult consortium as part of a competitive procurement exercise in accordance with the "Restricted" procedure for tendering under the Public Contracts Regulations 2015 (as amended from time to time).

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.6) Estimated value

Value excluding VAT: £20,000,000

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Restricted procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Date

20 December 2021

Local time

5:00pm

four.2.3) Estimated date of dispatch of invitations to tender or to participate to selected candidates

10 January 2022

four.2.4) Languages in which tenders or requests to participate may be submitted

English


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.2) Information about electronic workflows

Electronic invoicing will be accepted

Electronic payment will be used

six.4) Procedures for review

six.4.1) Review body

Catapult Cell and Gene Therapy

Cell and Gene Therapy Catapult, 4 Warner Drive, Springwood Industrial Estate

Braintree

CM72YW

Email

Tony.Morris@ct.Catapult.org.uk

Country

United Kingdom